FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156871337> ?p ?o ?g. }

• W2156871337 endingPage "7014" @default.
• W2156871337 startingPage "7009" @default.
• W2156871337 abstract "The demonstration that angiogenesis is required for the growth of solid tumors has fueled an intense interest in the development of new therapeutic strategies that target the tumor vasculature. Here we report the development of an immune-based antiangiogenic strategy that is based on the generation of T lymphocytes that possess a killing specificity for cells expressing vascular endothelial growth factor receptors (VEGFRs). To target VEGFR-expressing cells, recombinant retroviral vectors were generated that encoded a chimeric T cell receptor comprised of VEGF sequences linked to intracellular signaling sequences derived from the zeta chain of the T cell receptor. After transduction of primary murine CD8 lymphocytes by such vectors, the transduced cells were shown to possess an efficient killing specificity for cells expressing the VEGF receptor, Flk-1, as measured by in vitro cytotoxicity assays. After adoptive transfer into tumor-bearing mice, the genetically modified cytotoxic T lymphocytes strongly inhibited the growth of a variety of syngeneic murine tumors and human tumor xenografts. An increased effect on in vivo tumor growth inhibition was seen when this therapy was combined with the systemic administration of TNP-470, a conventional angiogenesis inhibitor. The utilization of the immune system to target angiogenic markers expressed on tumor vasculature may prove to be a powerful means for controlling tumor growth." @default.
• W2156871337 created "2016-06-24" @default.
• W2156871337 creator A5005526815 @default.
• W2156871337 creator A5027197124 @default.
• W2156871337 creator A5053371497 @default.
• W2156871337 creator A5062177133 @default.
• W2156871337 creator A5063861555 @default.
• W2156871337 creator A5066302335 @default.
• W2156871337 date "2002-05-07" @default.
• W2156871337 modified "2023-09-26" @default.
• W2156871337 title "Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors" @default.
• W2156871337 cites W10444853 @default.
• W2156871337 cites W1482104159 @default.
• W2156871337 cites W1490238624 @default.
• W2156871337 cites W1555790284 @default.
• W2156871337 cites W1570699702 @default.
• W2156871337 cites W1574443686 @default.
• W2156871337 cites W1748987851 @default.
• W2156871337 cites W1849770002 @default.
• W2156871337 cites W1936323503 @default.
• W2156871337 cites W1965380392 @default.
• W2156871337 cites W1982942806 @default.
• W2156871337 cites W1989064979 @default.
• W2156871337 cites W1989115595 @default.
• W2156871337 cites W2003572398 @default.
• W2156871337 cites W2003598961 @default.
• W2156871337 cites W2004347994 @default.
• W2156871337 cites W2004458954 @default.
• W2156871337 cites W2006351633 @default.
• W2156871337 cites W2007431577 @default.
• W2156871337 cites W2023371975 @default.
• W2156871337 cites W2023453327 @default.
• W2156871337 cites W2028460943 @default.
• W2156871337 cites W2030077709 @default.
• W2156871337 cites W2040643607 @default.
• W2156871337 cites W2050821833 @default.
• W2156871337 cites W2057860103 @default.
• W2156871337 cites W2069092801 @default.
• W2156871337 cites W2075086348 @default.
• W2156871337 cites W2081363606 @default.
• W2156871337 cites W2086157929 @default.
• W2156871337 cites W2093866433 @default.
• W2156871337 cites W2098671787 @default.
• W2156871337 cites W2105669313 @default.
• W2156871337 cites W2111266343 @default.
• W2156871337 cites W2116286338 @default.
• W2156871337 cites W2117013761 @default.
• W2156871337 cites W2126249291 @default.
• W2156871337 cites W2138798328 @default.
• W2156871337 cites W2144383844 @default.
• W2156871337 cites W2146651717 @default.
• W2156871337 cites W2146660124 @default.
• W2156871337 cites W2147153603 @default.
• W2156871337 cites W2155441992 @default.
• W2156871337 cites W2158743409 @default.
• W2156871337 cites W2159542715 @default.
• W2156871337 cites W2170285778 @default.
• W2156871337 cites W2401551085 @default.
• W2156871337 doi "https://doi.org/10.1073/pnas.092562399" @default.
• W2156871337 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/124519" @default.
• W2156871337 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11997459" @default.
• W2156871337 hasPublicationYear "2002" @default.
• W2156871337 type Work @default.
• W2156871337 sameAs 2156871337 @default.
• W2156871337 citedByCount "107" @default.
• W2156871337 countsByYear W21568713372012 @default.
• W2156871337 countsByYear W21568713372013 @default.
• W2156871337 countsByYear W21568713372014 @default.
• W2156871337 countsByYear W21568713372015 @default.
• W2156871337 countsByYear W21568713372016 @default.
• W2156871337 countsByYear W21568713372017 @default.
• W2156871337 countsByYear W21568713372018 @default.
• W2156871337 countsByYear W21568713372019 @default.
• W2156871337 countsByYear W21568713372020 @default.
• W2156871337 countsByYear W21568713372021 @default.
• W2156871337 countsByYear W21568713372022 @default.
• W2156871337 crossrefType "journal-article" @default.
• W2156871337 hasAuthorship W2156871337A5005526815 @default.
• W2156871337 hasAuthorship W2156871337A5027197124 @default.
• W2156871337 hasAuthorship W2156871337A5053371497 @default.
• W2156871337 hasAuthorship W2156871337A5062177133 @default.
• W2156871337 hasAuthorship W2156871337A5063861555 @default.
• W2156871337 hasAuthorship W2156871337A5066302335 @default.
• W2156871337 hasBestOaLocation W21568713372 @default.
• W2156871337 hasConcept C146285616 @default.
• W2156871337 hasConcept C150710994 @default.
• W2156871337 hasConcept C153911025 @default.
• W2156871337 hasConcept C154317977 @default.
• W2156871337 hasConcept C167672396 @default.
• W2156871337 hasConcept C167734588 @default.
• W2156871337 hasConcept C170493617 @default.
• W2156871337 hasConcept C202751555 @default.
• W2156871337 hasConcept C203014093 @default.
• W2156871337 hasConcept C2776090121 @default.
• W2156871337 hasConcept C2777025900 @default.
• W2156871337 hasConcept C2780394083 @default.
• W2156871337 hasConcept C502942594 @default.
• W2156871337 hasConcept C55493867 @default.

• next